We are live on !
Find out more
Axa Portfolio holdings
AUM
$91.9M
Turnover
57.14%
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.62%
5 Year Est. Return
+129.91%
10 Year Est. Return
+554.84%
AUM
$22.9B
AUM Growth
-$1.51B
(-6.2%)
Cap. Flow
-$3.16B
Cap. Flow % of AUM
Cap. Flow %
-13.8%
Top 10 Holdings %
Top 10 Hldgs %
13.28%
Holding
1,594
New
153
Increased
521
Reduced
511
Closed
199
Avg Time Held
1.6
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$299M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$201M |
| 3 |
Steris
STE
|
+$162M |
| 4 |
Yum! Brands
YUM
|
+$118M |
| 5 |
RTX Corp
RTX
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$755M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$510M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$380M |
| 4 |
Merck
MRK
|
+$205M |
| 5 |
HP
HPQ
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.46% |
| 2 | Financials | 12.37% |
| 3 | Technology | 12.16% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.09T
| $489M | 2.14% |
18,580,072
-5,124,504
| -22% | -$146M |
2013 Q2
10 quarters
|
|
2
Gilead Sciences
GILD
$205B
| $442M | 1.93% |
4,371,381
-173,452
| -4% | -$18M |
2013 Q2
10 quarters
|
|
3
Johnson & Johnson
JNJ
$662B
| $343M | 1.5% |
3,341,375
-598,681
| -15% | -$60.2M |
2013 Q2
10 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$3.49T
| $314M | 1.37% |
+8,071,200
| New | +$299M |
2015 Q4
0 quarters
|
|
5
Pfizer
PFE
$171B
| $268M | 1.17% |
8,762,366
-1,491,696
| -15% | -$46.9M |
2013 Q2
10 quarters
|
|
6
Amgen
AMGN
$249B
| $257M | 1.12% |
1,582,648
-820,834
| -34% | -$129M |
2013 Q2
10 quarters
|
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $239M | 1.04% |
1,994,818
+78,990
| +4% | +$9.14M |
2013 Q2
10 quarters
|
|
8
UBS Group
UBS
$146B
| $239M | 1.04% |
12,242,749
+397,691
| +3% | +$7.76M |
2014 Q4
4 quarters
|
|
9
Microsoft
MSFT
$3.94T
| $235M | 1.03% |
4,234,730
-514,358
| -11% | -$27.1M |
2013 Q2
10 quarters
|
|
10
Intel
INTC
$487B
| $212M | 0.93% |
6,167,135
-1,171,802
| -16% | -$39.6M |
2013 Q2
10 quarters
|
|
|
11
Alphabet (Google) Class C
GOOG
$3.47T
| $212M | 0.93% |
+5,597,800
| New | +$201M |
2015 Q4
0 quarters
|
|
12
Meta Platforms (Facebook)
META
$1.63T
| $211M | 0.92% |
2,015,148
+95,203
| +5% | +$9.8M |
2013 Q2
10 quarters
|
|
13
Wells Fargo
WFC
$255B
| $210M | 0.92% |
3,872,278
+18,744
| +0.5% | +$1.02M |
2013 Q2
10 quarters
|
|
|
14
Merck
MRK
$361B
| $210M | 0.92% |
4,171,806
-4,059,913
| -49% | -$205M |
2013 Q2
10 quarters
|
|
15
AT&T
T
$141B
| $208M | 0.91% |
8,011,450
+2,765,476
| +53% | +$70.1M |
2013 Q2
10 quarters
|
|
16
ExxonMobil
XOM
$754B
| $205M | 0.9% |
2,633,333
-447,660
| -15% | -$35.8M |
2013 Q2
10 quarters
|
|
17
Starbucks
SBUX
$120B
| $201M | 0.88% |
3,355,043
+886,547
| +36% | +$54M |
2013 Q2
10 quarters
|
|
18
Biogen
BIIB
$36.9B
| $180M | 0.79% |
588,916
+69,067
| +13% | +$19.8M |
2013 Q2
10 quarters
|
|
19
IBM
IBM
$244B
| $180M | 0.78% |
1,364,690
-436,719
| -24% | -$58.7M |
2013 Q2
10 quarters
|
|
20
Visa
V
$767B
| $176M | 0.77% |
2,266,612
-174,407
| -7% | -$13.5M |
2013 Q2
10 quarters
|
|
21
Booking.com
BKNG
$113B
| $172M | 0.75% |
3,363,350
+1,738,725
| +107% | +$91.8M |
2013 Q2
10 quarters
|
|
22
Amazon
AMZN
$2.63T
| $171M | 0.75% |
5,065,860
+411,560
| +9% | +$13M |
2013 Q2
10 quarters
|
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
| $170M | 0.74% |
888,596
+4,762
| +0.5% | +$832K |
2013 Q2
10 quarters
|
|
|
24
Steris
STE
$22.6B
| $169M | 0.74% |
+2,247,447
| New | +$162M |
2015 Q4
0 quarters
|
|
25
DuPont de Nemours
DD
$19B
| $163M | 0.71% |
1,253,939
-167,390
| -12% | -$21.5M |
2013 Q2
10 quarters
|
|
Similar funds
HI
Axa's Q4 2015 Portfolio in Review
As of Q4 2015, Axa held 1,594 positions worth $22.9B, down 6.2% from $24.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Axa withdrew a net $3.16B in Q4 2015, closing 199 positions and reducing 511 holdings. Its most notable exit was iShares 3-7 Year Treasury Bond ETF, an estimated $755M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Alphabet (Google) Class A worth $314M.
- Axa's largest Q4 2015 buy was Alphabet (Google) Class A: 8,071,200 shares worth $314M.
- Axa added most to Yum! Brands in Q4 2015, an estimated $118M increase.
- Axa's biggest Q4 2015 reduction was Merck, cutting an estimated $205M.
- Axa fully exited iShares 3-7 Year Treasury Bond ETF in Q4 2015, selling an estimated $755M.
- Axa's ten largest holdings make up 13% of its $22.9B portfolio in Q4 2015.
- Axa opened 153 new positions and closed 199 in Q4 2015.
- Axa's portfolio value fell 6.2% quarter-over-quarter to $22.9B.
Based on Axa's 13F filing for Q4 2015, filed 12 Feb 2016.